A Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer
Study Number: 

PH 284416

Phase: 
3
Trial categories: 
Bladder
Urothelial, Transitional Cell
Immunotherapy
Antibody therapy
Checkpoint blockade
Principal Investigator: